Insider Transactions in Q4 2022 at Madrigal Pharmaceuticals, Inc. (MDGL)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2022
|
Remy Sukhija Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-27.87%
|
$8,250,000
$275.27 P/Share
|
|
Dec 23
2022
|
Remy Sukhija Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
$1,800,000
$60.26 P/Share
|
|
Dec 23
2022
|
Brian Joseph Lynch SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
7,000
-26.86%
|
$1,925,000
$275.28 P/Share
|
|
Dec 23
2022
|
Brian Joseph Lynch SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$637,000
$91.79 P/Share
|